Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

TAIWAN: U.S. Drug Company to Team Up With Local School on Hepatitis B Cure


Focus Taiwan (06.03.2013)

On June 3, the US pharmaceutical company Janssen-Cilag announced that it would collaborate with National Taiwan University to find a cure for hepatitis B within the next decade. Janssen-Cilag plans to invest $6.6 million throughout the next three years in a joint study with the university. Researchers hope to have new drug candidates within three years and complete clinical trials for a new hepatitis B drug within eight years. According to Chen Pei-jer, professor with National Taiwan University Hospital’s Graduate Institute of Clinical Medicine and research project lead, current hepatitis B drugs were limited by the fact that they could keep the virus in check but could not cure the illness.


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in June 6, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.